Jean–Louis Jouve
CHU Dijon Bourgogne(FR)Maison des Sciences sociales et des Humanités de Dijon(FR)
Publications by Year
Research Areas
Hepatocellular Carcinoma Treatment and Prognosis, Liver Disease Diagnosis and Treatment, Gastric Cancer Management and Outcomes, Colorectal Cancer Treatments and Studies, Genetic factors in colorectal cancer
Most-Cited Works
- → Gemcitabine and Oxaliplatin Chemotherapy or Surveillance in Resected Biliary Tract Cancer (PRODIGE 12-ACCORD 18-UNICANCER GI): A Randomized Phase III Study(2019)511 cited
- → Geriatric Factors Predict Chemotherapy Feasibility: Ancillary Results of FFCD 2001-02 Phase III Study in First-Line Chemotherapy for Metastatic Colorectal Cancer in Elderly Patients(2013)213 cited
- → Arterial Embolotherapy for Endoscopically Unmanageable Acute Gastroduodenal Hemorrhage: Predictors of Early Rebleeding(2009)204 cited
- → Gemox versus surveillance following surgery of localized biliary tract cancer: Results of the PRODIGE 12-ACCORD 18 (UNICANCER GI) phase III trial.(2017)110 cited
- → Colorectal adenocarcinoma in patients under 45 years of age(2001)110 cited
- → Pravastatin combination with sorafenib does not improve survival in advanced hepatocellular carcinoma(2019)